polibar prašek za rektalno suspenzijo
mark medical d.o.o. - prašek za rektalno suspenzijo - barijev(ii) sulfat z suspendirajočimi sredstvi
ibrance
pfizer europe ma eeig - palbociclib - neoplazme dojke - antineoplastična sredstva - ibrance je primerna za zdravljenje hormonsko receptorjev (hr) pozitiven, human epidermalna rast factor receptor 2 (her2) negativne lokalno napredno ali metastatski rak dojk:v kombinaciji z zaviralec aromataze;v kombinaciji z fulvestrant pri ženskah, ki jih prejeli v pred endokrine terapija. v pre - ali perimenopausal ženske, endokrini terapija je treba v kombinaciji z luteinizirajoči hormon sproščujoči hormon (lhrh) agonist.
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazme dojke - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
kisqali
novartis europharm limited - ribociklib sukcinat - neoplazme dojke - antineoplastična sredstva - kisqali je primerna za zdravljenje žensk z hormon receptorjev (hr)‑pozitiven, human epidermalna rast factor receptor 2 (her2)‑negativna lokalno napredno ali metastatskega raka dojke, v kombinaciji z zaviralec aromataze ali fulvestrant kot začetno endokrine temelji na zdravljenje, ali pri ženskah, ki jih prejeli v pred endokrine terapija. v pre‑ ali perimenopausal ženske, endokrini terapija je treba v kombinaciji z luteinising hormon sproščujoči hormon (lhrh) agonist.
entericolix
cz vaccines -
trisulfon peroralna suspenzija - np
trisulfon peroralni prasek
krka -
neocolipor
boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - zmanjšanje neonatalne enterotoksikoze pujskov, ki jih povzroča e. coli, izražajo adhezine f4ab, f4ac, f4ad, f5, f6 in f41, v prvih dneh življenja.
cefaximin l
fatro -
rhemox 500 mgg prasek
industrial veterinaria -